Funder
This study supported by Infectious and Tropical Diseases Research Centre, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Microbiology (medical),Immunology,General Medicine,Immunology and Allergy
Reference53 articles.
1. Gupta AK, Foley KA, Versteeg SG (2017) New antifungal agents and new formulations against dermatophytes. Mycopathologia 182(1–2):127–141. https://doi.org/10.1007/s11046-016-0045-0
2. Jarratt M, Jones T, Adelglass J et al (2014) Efficacy and safety of once-daily luliconazole 1% cream in patients ≥ 12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind, vehicle-controlled study. J Drugs Dermatol 13(7):838–846
3. Jones T, Tavakkol A (2013) Safety and tolerability of luliconazole solution 10% in patients with moderate to severe distal subungual onychomycosis. Antimicrob Agents Chemother 57(6):2684–2689. https://doi.org/10.1128/AAC.02370-12
4. Watanabe S, Takahashi H, Nishikawa T et al (2006) A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedis. Mycoses 49(3):236–241. https://doi.org/10.1111/j.1439-0507.2006.01218.x
5. Wiederhold NP, Fothergill AW, McCarthy DI, Tavakkol A (2014) Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis. Antimicrob Agents Chemother 58(6):3553–3555. https://doi.org/10.1128/AAC.02706-13
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献